AQR Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-39,707
| Closed | -$1.56M | – | 2429 |
|
|
2023
Q2 | $1.56M | Buy |
39,707
+18,521
| +87% | +$654K | ﹤0.01% | 1369 |
|
|
2023
Q1 | $515K | Buy |
21,186
+3,218
| +18% | +$70.5K | ﹤0.01% | 1770 |
|
|
2022
Q4 | $385K | Sell |
17,968
-806
| -4% | -$17.2K | ﹤0.01% | 1901 |
|
|
2022
Q3 | $337K | Sell |
18,774
-8,047
| -30% | -$106K | ﹤0.01% | 1912 |
|
|
2022
Q2 | $258K | Sell |
26,821
-599
| -2% | -$7.52K | ﹤0.01% | 1910 |
|
|
2022
Q1 | $461K | Sell |
27,420
-57,189
| -68% | -$845K | ﹤0.01% | 1849 |
|
|
2021
Q4 | $1.42M | Buy |
84,609
+46,151
| +120% | +$756K | ﹤0.01% | 1379 |
|
|
2021
Q3 | $625K | Buy |
+38,458
| New | +$419K | ﹤0.01% | 1774 |
|
|
2021
Q2 | – | Sell |
-37,657
| Closed | -$233K | – | 2319 |
|
|
2021
Q1 | $233K | Sell |
37,657
-133,063
| -78% | -$808K | ﹤0.01% | 2072 |
|
|
2020
Q4 | $1.18M | Buy |
170,720
+39,988
| +31% | +$256K | ﹤0.01% | 1429 |
|
|
2020
Q3 | $737K | Buy |
+130,732
| New | +$623K | ﹤0.01% | 1568 |
|
|
2017
Q3 | – | Sell |
-67,444
| Closed | -$173K | – | 2305 |
|
|
2017
Q2 | $173K | Buy |
+67,444
| New | +$184K | ﹤0.01% | 2145 |
|
|
2016
Q2 | – | Sell |
-10,031
| Closed | -$424K | – | 2278 |
|
|
2016
Q1 | $424K | Sell |
10,031
-150
| -1% | -$7.64K | ﹤0.01% | 1890 |
|
|
2015
Q4 | $800K | Sell |
10,181
-13,958
| -58% | -$807K | ﹤0.01% | 1676 |
|
|
2015
Q3 | $978K | Sell |
24,139
-4,250
| -15% | -$225K | ﹤0.01% | 1441 |
|
|
2015
Q2 | $1.48M | Buy |
28,389
+1,889
| +7% | +$94K | ﹤0.01% | 1323 |
|
|
2015
Q1 | $1.23M | Buy |
26,500
+8,900
| +51% | +$462K | ﹤0.01% | 1323 |
|
|
2014
Q4 | $790K | Buy |
+17,600
| New | +$739K | ﹤0.01% | 1752 |
|
AQR Capital Management's ISEE Position: Q3 2023 in Review
AQR Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 39,707 shares — an estimated $1.56M sold.
AQR Capital Management first reported a position in ISEE in Q4 2014 and held it in 18 quarters. The position peaked at $1.56M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- AQR Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- AQR Capital Management sold 39,707 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.56M.
- AQR Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 18 quarters.
- AQR Capital Management's IVERIC bio, Inc. Common Stock position peaked at $1.56M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on AQR Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.